Rheumatology (Oxford, England) · 2026
Immunophenotyping and machine learning-based stratification reveal prognostic immune signatures in Behçet's disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ao Yiyuan, Li Lu, Liu Jinjing, Qin Ling, Wang Li, Zhao Lidan, Zhao Yan, Cao Wei, Li Taisheng, Zheng Wenjie
Аннотация
OBJECTIVE: The aim was to characterize peripheral blood lymphocyte subsets in BD patients, and to stratify patient subgroups and identify prognostic biomarkers.
METHOD: Immunophenotyping of 11 immune cell subsets was performed using flow cytometry in peripheral blood samples from treatment-naive BD patients (n = 71) and age- and sex-matched healthy controls (HCs) (n = 71). XGBoost, PLS-DA and k-means clustering were employed to analyse the immune profiles and stratify BD patients based on their immunological subtypes and clinical parameters. Kaplan-Meier analysis and log-rank tests were used to compare relapse-free survival across BD patient clusters. Cox regression analysis was used to assess the clinical and immunological predictors of relapse.
RESULTS: Our study reveals a T-cell dominant immune dysregulation in BD patients compared with HCs. Machine learning integration of immunophenotyping and clinical parameters identified two BD subgroups. Cluster 2 exhibited hyperactivated T cells (increased memory CD4+ T cells, CD8+DR+ T cells and CD8+CD38+ T cells), higher inflammatory markers (hsCRP, ESR, NLR and PLR), higher disease severity scores and relapse risk. Multivariate Cox regression analysis revealed that high hsCRP and CD8+DR+T-cells proportion were independent predictors of relapse. The HR-weighted combinations of CD8+DR+T%, hsCRP and disease severity scores exhibited superior relapse predictive performance (AUC = 0.815).
CONCLUSION: This study provided a comprehensive immunophenotypic profile of treatment-naive BD patients. Machine learning integration of lymphocyte subsets and clinical parameters enabled the identification of subgroups at high risk of relapse at an early stage, providing a rationale for personalized treatment strategies.
METHOD: Immunophenotyping of 11 immune cell subsets was performed using flow cytometry in peripheral blood samples from treatment-naive BD patients (n = 71) and age- and sex-matched healthy controls (HCs) (n = 71). XGBoost, PLS-DA and k-means clustering were employed to analyse the immune profiles and stratify BD patients based on their immunological subtypes and clinical parameters. Kaplan-Meier analysis and log-rank tests were used to compare relapse-free survival across BD patient clusters. Cox regression analysis was used to assess the clinical and immunological predictors of relapse.
RESULTS: Our study reveals a T-cell dominant immune dysregulation in BD patients compared with HCs. Machine learning integration of immunophenotyping and clinical parameters identified two BD subgroups. Cluster 2 exhibited hyperactivated T cells (increased memory CD4+ T cells, CD8+DR+ T cells and CD8+CD38+ T cells), higher inflammatory markers (hsCRP, ESR, NLR and PLR), higher disease severity scores and relapse risk. Multivariate Cox regression analysis revealed that high hsCRP and CD8+DR+T-cells proportion were independent predictors of relapse. The HR-weighted combinations of CD8+DR+T%, hsCRP and disease severity scores exhibited superior relapse predictive performance (AUC = 0.815).
CONCLUSION: This study provided a comprehensive immunophenotypic profile of treatment-naive BD patients. Machine learning integration of lymphocyte subsets and clinical parameters enabled the identification of subgroups at high risk of relapse at an early stage, providing a rationale for personalized treatment strategies.